2020 American Transplant Congress » Liver: Hepatocellular Carcinoma and Other Malignancies II
Date: Saturday, May 30, 2020
Time: 3:15pm-4:45pm
Location: Virtual
Session Type: Oral Abstract Session
Meeting: 2020 American Transplant Congress
- 3:15pm-3:27pm
Graft Survival after Liver Transplantation for Patients with Cholangiocarcinoma
I. A. Ziogas, L. A. Hickman, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. A. Rega, I. D. Feurer, S. P. Alexopoulos
- 3:27pm-3:39pm
Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells
M. Ohira1, R. Hotta1, Y. Imaoka1, K. Sato1, N. Tanimine1, H. Tahara1, K. Ide1, T. Kobayashi1, Y. Tanaka1, A. Tzakis2, S. Nishida2, H. Ohdan1
- 3:39pm-3:51pm
Cirrhosis-Driven Immune Dysfunction is Associated with Poor Response to DEB-TACE and Waitlist Dropout in Hepatocellular Carcinoma Patients While Awaiting Liver Transplantation
K. Nunez, T. Sandow, M. Hibino, A. Cohen, P. Thevenot
- 3:51pm-4:03pm
Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients
K. Nunez, T. Sandow, P. Thevenot, A. Cohen
- 4:03pm-4:15pm
Liver Transplantation for Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Survival Rates
I. A. Ziogas1, K. P. Economopoulos2, M. H. Hayat1, L. K. Matsuoka1, M. I. Montenovo1, M. Izzy1, S. P. Alexopoulos1
- 4:15pm-4:27pm
Prognostic Index of Circulating Tumor Cells for Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
M. Chen1, Z. Chen1, X. Lin2, W. Ju1, X. He1
- 4:27pm-4:39pm
The Perioperative Coagulation Profile of Hepatocellular Carcinoma During Liver Transplantation Compared to Patients with Non-Malignant Disease: A Cause or Association for Decreased Blood Product Utilization During Liver Transplantation?
H. B. Moore, E. Pomfret, J. Pomposelli, C. Walker, R. Choudhury, H. Yaffe, M. Wachs, T. Bak, K. Conzen, M. Adams, T. Pshak, T. L. Nydam
« View all sessions from the 2020 American Transplant Congress